Calcium Citrate and Vitamin D in the Treatment of Osteoporosis
- PDF / 194,919 Bytes
- 14 Pages / 504.57 x 720 pts Page_size
- 77 Downloads / 210 Views
Clin Drug Investig 2011; 31 (5): 285-298 1173-2563/11/0005-0285/$49.95/0
ª 2011 Adis Data Information BV. All rights reserved.
Calcium Citrate and Vitamin D in the Treatment of Osteoporosis Jose´ Manuel Quesada Go´mez,1 Josep Blanch Rubio´,2 Manuel Dı´az Curiel3 and Adolfo Dı´ez Pe´rez4 1 Mineral Metabolism Unit, Hospital Universitario Reina Sofı´a, Co´rdoba, Spain 2 IMAS Rheumatology Department, Hospital Universitario del Mar, Barcelona, Spain 3 Department of Internal Medicine/Bone Metabolism Disorders, Fundacio´n Jime´nez Dı´az, Madrid, and Bone Metabolism Disorders, Universidad Auto´noma, Madrid, Spain 4 Department of Internal Medicine and Infectious Diseases, Hospital del Mar-IMIM, Universidad Auto´noma de Barcelona, Barcelona, Spain
Contents Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2. Physiology of Calcium Absorption . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.1 Gastric Secretion and Calcium Absorption . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.2 Epithelial Transport and Calcium Absorption. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.2.1 Paracellular Transport. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.2.2 Transcellular Transport . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3. Properties of Commonly Used Calcium Salts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4. Calcium Citrate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.1 Absorption and Bioavailability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.2 Safety and Tolerability. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5. Compliance with Drug Treatment Used in Osteoporosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abstract
285 286 287 288 288 289 289 290 290 290 291 294 294
The combination of calcium with vitamin D (vitamin D3 [colecalciferol]) forms the basis of preventive and therapeutic regimens for osteoporosis. A number of studies have suggested that the combination of calcium and vitamin D is effective when administered at respective dosages of at least 1200 mg and 800 IU per day, alth
Data Loading...
